Yth1, a subunit of yeast Cleavage Polyadenylation Factor (CPF), contains ®ve CCCH zinc ®ngers. Yth1 was previously shown to interact with pre-mRNA and with two CPF subunits, Brr5/Ysh1 and the polyadenylation-speci®c Fip1, and to act in both steps of mRNA 3¢ end processing. In the present study, we have identi®ed new domains involved in each interaction and have analyzed the consequences of mutating these regions on Yth1 function in vivo and in vitro. We have found that the essential fourth zinc ®nger (ZF4) of Yth1 is critical for interaction with Fip1 and RNA, but not for cleavage, and a single point mutation in ZF4 impairs only polyadenylation. Deletion of the essential N-terminal region that includes the ZF1 or deletion of ZF4 weakened the interaction with Brr5 in vitro. In vitro assays showed that the N-terminus is necessary for both processing steps. Of particular importance, we ®nd that the binding of Fip1 to Yth1 blocks the RNA±Yth1 interaction, and that this inhibition requires the Yth1-interacting domain on Fip1. Our results suggest a role for Yth1 not only in the execution of cleavage and poly(A) addition, but also in the transition from one step to the other.
INTRODUCTION
In eukaryotes, accurate processing of the 3¢ ends of primary transcripts is an essential step that promotes transcription termination (1±3) and transport of mRNA from the nucleus (4±6). Cells are able to change the type and amount of mRNA derived from many genes by regulation of this step (7, 8) . The resulting poly(A) tail is also important for optimal translation and for determining mRNA stability (9±12).
The processing of the 3¢ end of the primary transcripts consists of a tightly coupled two-step reaction involving sitespeci®c endonucleolytic cleavage and poly(A) addition onto the upstream cleaved product. This reaction requires cis-acting signal sequences on the RNA and trans-acting protein components (13, 14) . Uncoupling cleavage and polyadenylation in vitro (15, 16) led to the biochemical identi®cation of factors involved in either one or both steps of the process. In Saccharomyces cerevisiae, fractionation of whole cell extracts has identi®ed ®ve functionally distinct activities involved in cleavage and polyadenylation (17, 18) . Cleavage requires Cleavage Factor I (CF I) and Cleavage Factor II (CF II), while tail synthesis requires poly(A) polymerase (Pap1), CF I, CF II, Polyadenylation Factor I (PF I), and poly(A) binding protein (Pab1). CF I consists of ®ve subunits, Rna14, Rna15, Pcf11, Clp1 and Hrp1 (18±21). PF I can also be isolated as part of a larger complex that contains CF II components, and has been designated Cleavage Polyadenylation Factor (CPF) (21, 22) . CPF includes Pap1, Fip1, Pta1, Mpe1, Pfs2, Cft1/ Yhh1, Cft2/Ydh1, Brr5/Ysh1, Yth1 (21, 23) and additional uncharacterized proteins (24) . A subcomplex consisting of Cft1, Cft2, Brr5 and Pta1 was found to carry out CF II activity (25, 26) . Homologs for many of the CF I and CPF subunits have been found in higher eukaryotes (21,25,27±29) , illustrating the conserved nature of this process.
In yeast, at least four cis-acting signals are important for mRNA 3¢ end processing: a UA-rich element found at a variable distance upstream of the poly(A) site (30) , an A-rich element located~20 nt upstream of the poly(A) site (31, 32) , U-rich sequences around the poly(A) site (33, 34) and the poly(A) site, whose sequence is most frequently Py(A) n (35, 36) . The 3¢ processing complex must contain RNA binding subunits that recognize these individual signals and thus direct the protein complex to a pre-mRNA for cleavage at the poly(A) site. In CF I, these are Hrp1, which interacts with the UA-rich element (37±40), and Rna15, which binds speci®cally to the A-rich element when Hrp1 and Rna14 are present (40) . Among CPF subunits, at least three proteins (Cft1, Cft2 and Yth1) have RNA-binding properties. UV cross-linking experiments with puri®ed CF II showed that Cft2 is cross-linked to GAL7 mRNA only when the UA-rich element is present (25) . RNase H protection assays demonstrated that the CPF complex, as well as Cft1, Cft2 and Yth1 individually, interacts with the region around the CYC1 RNA poly(A) site (41±43).
As our knowledge of eukaryotic cleavage/polyadenylation factors increases, further understanding of the molecular mechanism underlying this essential process will require a thorough dissection of how the interactions of these factors with each other and with substrate promote cleavage, the transition from a cleavage to a polyadenylation complex, and processive synthesis of a correctly sized poly(A) tail. In this study, we focus such an analysis on Yth1, a 24 kDa subunit of CPF known to be essential for both cleavage and polyadenylation (29, 41) . Yth1 and its mammalian homolog CPSF-30 contain a well conserved central section of ®ve CCCH zinc ®ngers, with regions of divergent sequence on either side (29) . Members of the rare CCCH zinc ®nger family have in common two or more repeats of a motif consisting of Cys and His residues in the form CX 8 CX 5 CX 3 H. Proteins bearing this motif have roles in RNA binding, RNA localization and RNA stability in a wide variety of organisms (44±48). Zinc ®ngers in general have been implicated not only in nucleic acid binding but also in protein±protein interactions (49, 50) .
In addition to the interaction of Yth1 and RNA described above, Yth1 interacts with Fip1, whose binding to Pap1 regulates this enzyme's activity and connects it to the processing machinery (29, 51) . Yth1 also associates with Brr5 (41), a CPF subunit necessary for both steps of processing (27) . The structure of Yth1 suggests that it is organized into seven discrete domains that might contribute in unique ways to Yth1 function. Experimental evidence has begun to support this conclusion. Barabino et al. (29, 41) showed that a deletion of the C-terminus that includes most of ZF5 (yth1-1) weakened the interaction with Fip1 and abrogated polyadenylation. However, mutation of a highly conserved residue in ZF2 (yth1-4) demonstrated that Yth1 was important for both cleavage and polyadenylation. This mutation preserved Fip1 binding but interfered with the interaction with RNA and the rest of CPF. In addition, a mutation of H142N in ZF4 (yth1-5) caused shorter poly(A) tails but had no effect on cleavage.
In this study, we create mutations throughout the protein to identify functions for the other Yth1 domains and to clarify the roles of ZF4 and the C-terminus. For example, we have found that ZF2 and ZF4 are both essential for RNA interaction and deletion of either one causes lethality. However, further analysis shows that these two zinc ®ngers have different functions. Yth1 lacking ZF2 cannot rescue the in vitro cleavage defect of a yth1-4 mutant extract. In contrast, Yth1 without ZF4 can function in cleavage, but shows no interaction with Fip1, a protein essential for poly(A) addition. Moreover, we ®nd that Fip1 inhibits the interaction between Yth1 and RNA. Our results suggest that rearrangement of the postcleavage complex to one active for polyadenylation might involve a switch in which ZF4 binds Fip1 instead of RNA.
MATERIALS AND METHODS

Strains
The YTH1 knockout strain SB7 carrying the yth1-1 allele was a kind gift from Drs Silvia M. L. Barabino and Walter Keller. SB7 (29) was used to create the strain YT1 with a disruption of the chromosomal copy of the essential YTH1 gene and a centromeric vector containing the wild-type YTH1 gene and a URA3 selectable marker [MATa, ade2, leu2, ura3, trp1D, his3, yth1::TRP1, YCplac33-YTH1 (CEN4 URA3 YTH1)]. Plasmids carrying a LEU2 marker and a mutated YTH1 gene were introduced into YT1. These transformants were plated on 5-¯uoroorotic acid (5-FOA) medium to force loss of the plasmid carrying the wild-type YTH1 gene. The resulting yeast strains, YT2 [same as YT1 but YCplac11-YTH1 (CEN4 LEU2 YTH1)], YT3 (YCplac11-yth1DN1), YT4 (YCplac11-yth1DZ3), YT5 (YCplac11-yth1DC2), YT6 (YCplac11-yth1DC1), YT7 (YCplac11-yth1G130R) and YT8 (YCplac11-GST-YTH1) were used in this study. The mutation G130R was created by error-prone PCR (52) .
RNA processing assays
Yeast cell extracts were prepared as described previously (17) . After the ammonium sulfate precipitation, the proteins were resuspended in 100 ml of buffer D (20 mM Tris±HCl, pH 8.0, 50 mM KCl, 0.2 mM EDTA, 0.5 mM DTT, 20% glycerol, 2 mM pepstatin A, 0.6 mM leupeptin, 1 mM phenylmethylsulfonyl¯uoride) and dialyzed twice against 1 l of the same buffer for 2 h each. Preparation of [a-32 P]UTP-labeled fulllength GAL7-1 or pre-cleaved GAL7-9 RNAs by run-off transcription and processing assays were carried out as described previously (17) . In a total volume of 10 ml, 10 nM RNA (250 000 c.p.m.) was incubated with 1 ml of extract at 30°C for 30 min. The RNA products were resolved on a 5% polyacrylamide±8 M urea gel, and visualized with a PhosphorImager (Storm 860; Molecular Dynamics). For the complementation of cleavage activity in processing-de®cient extracts with recombinant proteins, we used 300 ng of GSTYth1 mutants and substituted dATP for ATP. The strength of the reaction product bands was quantitated by the NIH Image 1.62 program, and divided by number of uridines to normalize the amount of radioactivity in each band.
Recombinant proteins
The coding sequences of Yth1 mutants were cloned into pET21b(+) (Novagen) in a way that removed the His 6 -tag, and the recombinant proteins were expressed in Escherichia coli BL21(DE3) pLysS using the T7 expression system (53) . The Yth1 proteins were applied onto a DEAE-Sephacel column and the¯ow-through fractions were collected and used for coimmunoprecipitation as previously described (51) . The GSTfused Yth1 deletions were derived from pGEX-6P-2 (Pharmacia). A one step af®nity puri®cation on glutathioneSepharoseÔ 4B (Pharmacia) was carried out according to the manufacturer's instructions. Recombinant His 6 -Fip1 and Pap1 were expressed and puri®ed as described previously (51, 54) . The yeast plasmid containing the BRR5 gene with the HA 3 -tag at its C-terminus, pSE360-BRR5(HA) 3 , was recovered from the yeast strain YOM7 (27) which was a kind gift from Dr Christine Guthrie. The coding sequence of Brr5-HA 3 was cloned into pET-16b (Novagen) and His 6 -Brr5-HA 3 was expressed in E.coli BL21-SI (Gibco BRL). The His 6 -Brr5-HA 3 was puri®ed on Ni-NTA agarose (Qiagen) according to the manufacturer's instructions.
Co-immunoprecipitation
For each immunoprecipitation, 20 ml of a 50% slurry of protein A-agarose (Gibco BRL) was incubated with 10 ml of the monoclonal penta-His antibody (Qiagen) in buffer IP-150 (150 mM KCl, 20 mM Tris±HCl, pH 8.0, 0.1% NP-40) for 2 h at room temperature. The beads were washed with 1 ml of IP-150 three times and resuspended in 100 ml of IP-150 containing 10% fetal calf serum. After incubation for 1 h at 4°C, 500 ng of His 6 -Fip1 and 6±64 mg of total protein Nucleic Acids Research, 2003, Vol. 31, No. 6 1745 preparation of each recombinant Yth1 were added to the beads. This mixture was incubated for 1 h at 4°C and beads washed with 1 ml of IP-150 three times. The bound proteins were eluted in gel loading buffer containing SDS, and applied on a 12% SDS±polyacrylamide gel. The resolved proteins were immobilized onto a PVDF membrane and detected by immunoblotting with mouse polyclonal antibodies against Fip1 and Yth1 (51). To avoid heavy cross-reaction of the immunoprecipitating antibody with the secondary antibody during the western blotting, the primary and secondary antibodies were preincubated as described previously (55) . Reacted His 6 -Fip1 and Yth1 mutants were visualized by the color reaction using a chromagenic substrate for the enzyme alkaline phosphatase (Gibco BRL) according to the manufacturer's instructions.
Yth1 and yth1G130R were in vitro translated using TNT â T7 Coupled Reticulocyte Lysate System (Promega) and labeled with [ 35 S]methionine according to the manufacturer's instructions. Protein A beads were prepared as described above, and 15 ml of each translation reaction and 500 ng of His 6 -Fip1 were added. Co-immunoprecipitation was performed as described above, and the resolved proteins were visualized by exposing on X-ray ®lms.
GST pull-downs
For each reaction, 20 ml of a 50% slurry of glutathioneSepharoseÔ 4B (Pharmacia) was incubated in 100 ml of IP-150 containing 10% fetal calf serum. After incubation for 1 h at 4°C, a mixture of 500 ng of puri®ed GST-Yth1 and 500 ng of His6-Brr5-HA 3 was added to the beads. This mixture was incubated for 2 h at 4°C and beads washed with 1 ml of IP-150 three times. The bound proteins were eluted in 50 mM glutathione and applied onto a 10% SDS±polyacrylamide gel. The resolved proteins were immobilized on a PVDF membrane and detected by immunoblotting with rabbit polyclonal antibody against HA (Santa Cruz Biotechnology) and monoclonal antibody against GST (BD Biosciences). Visualization was carried out as described above.
UV cross-linking assays
Yth1 (200 ng), a-32 P-labeled GAL7-1 prepared as described above (100 000 c.p.m.), 0.1 mg yeast tRNA, 1 mM magnesium acetate, 75 mM potassium acetate, 10 mM HEPES±KOH, pH 7.0, 2% PEG 8000 and 1 mM DTT were incubated for 10 min at 30°C. After incubation, the mixture was irradiated with 1.2 mJ of energy with a UV Stratalinker model 2400 (Stratagene) on ice. RNA was digested with 4 mg of RNase A for 1 h at 37°C, and then proteins were separated on a 10% SDS±polyacrylamide gel. The gel was stained with Silver Stain Plus (Bio-Rad) and exposed to a PhosphorImager screen (Storm 860; Molecular Dynamics). For RNA binding competition assays, 300 ng of GST-Yth1 was incubated with 66±660 ng of Fip1 or ®p1-206 for 10 min at 30°C in 5 ml buffer D followed by the cross-linking assay described above.
RESULTS
Mutation of each Yth1 domain causes a different phenotype in vivo
To investigate whether the multiple zinc ®nger domains of Yth1 had distinct or overlapping functions, we decided to precisely delete different zinc ®ngers and test the deletions for viability, for activity in cleavage and polyadenylation, and for interaction with Fip1, Brr5 and RNA. There is a large amount of data indicating that such a deletion analysis of Yth1 would be a valid approach to understand Yth1 function. Numerous structural studies of DNA-binding zinc ®nger proteins have shown that each zinc ®nger motif forms a small, functional, independently folded mini-domain, and that the mode of DNA recognition is principally a one-to-one interaction between amino acids of the recognition helix and bases of the DNA (50, 56) . Deletion analysis of wig-1 (p53-induced mouse zinc ®nger protein) showed that the ®rst zinc ®nger is essential for binding to double-stranded RNA, whereas zinc ®ngers 2 and 3 are dispensable (57) . In a similar approach, it was found that zinc ®ngers 2±4 of MTF-1 (metal response element-binding transcription factor-1) are involved in DNA binding, whereas the ®rst zinc ®nger appears to function as a metal-sensing domain (58) . As the following results demonstrate, each Yth1 zinc ®nger deletion retained one or more of the known activities of Yth1, suggesting that the mutant proteins are folding properly. In addition to function of the different zinc ®ngers, we were interested in whether the unique regions of either end of Yth1 were important for Yth1 function.
To determine which regions of Yth1 are necessary for cell viability, we replaced the wild-type YTH1 gene with the deletions depicted in Figure 1A using plasmid shuf¯ing and 5-FOA selection as described in Materials and Methods. As shown in Figure 1B , a yeast strain carrying a deletion of the central 24 amino acids of the third zinc ®nger (ZF3) domain (yth1DZ3) shows no growth defect when compared to growth of the wild-type strain. Similarly, normal growth is observed when a yeast strain carries a construct with deletion of the C-terminal 33 amino acids (yth1DC1). These results suggest that these regions are dispensable for cell growth.
However, a strain with a deletion of the N-terminal 25 amino acids (yth1DN1) grows slowly at the permissive temperature of 30°C, and cannot grow at 37°C. Furthermore, a longer deletion of the N-terminal 56 amino acids including ZF1 (yth1DN2) is lethal. From these results, we conclude that the N-terminal region up to position 56 is essential for Yth1 function. Temperature sensitivity is also observed when a strain carries deletion of the C-terminal 61 amino acids (yth1DC2), which includes the ®fth zinc ®nger. This phenotype is similar to the mutant allele yth1-1 that carries a deletion of 50 amino acids at the C-terminus, as shown by Barabino et al. (29) . In contrast to yth1DN1, the yth1DC2 strain grows normally at the permissive temperature and slowly at 37°C. The non-essential nature of the last 33 amino acids suggests that the critical domain removed in yth1DC2 may be ZF5. However, we cannot exclude the possibility of an additive effect due to deletion of both regions.
Deletion of ZF2 from amino acids 67 to 86 (yth1DZ2) and deletion of the 28 amino acids spanning ZF4 (yth1DZ4) are lethal, suggesting that ZF2 and ZF4 are essential. Deletion of the central 52 amino acids including ZF3 and ZF4 (yth1DZ3/4) is also lethal, in agreement with the results that ZF4 is essential. A substitution of the conserved glycine residue for arginine at position 130 in ZF4 gives a temperature-sensitive yeast strain (yth1G130R). This result further supports the idea that ZF4 is responsible for an essential function. Finally, none of the viable mutants are cold-sensitive when grown at 16°C.
We next performed western blot analysis to detect Yth1 in cell extracts and determine whether the growth defects might be the consequence of poor expression of the mutant Yth1. As shown in Figure 2A , the temperature-sensitive yth1 mutants were successfully immunodetected in these extracts. In the extract from the strain carrying yth1DN1, a degradation product was also detected, although the protein level of yth1DN1 was similar to that of wild-type Yth1 (Fig. 2A,  lane 2) . The protein levels of yth1DC2 and yth1G130R were only slightly reduced compared to wild-type Yth1 (Fig. 2A,  lanes 3 and 4) . We also analyzed the levels of eight other processing components (Cft2, Brr5, Pta1, Rna14, Hrp1, Pap1, Fip1 and Rna15) in these extracts, in order to determine whether depletion of other components contributed to the growth de®ciency of the mutant strains. In these extracts, all of the protein levels were constant except for that of Fip1, which showed a very small reduction ( Fig. 2A) .
To examine the expression of the lethal mutants (yth1DN2, DZ2, DZ3/4 and DZ4), we asked whether these proteins could be detected in extracts from strains expressing the lethal mutations in a YTH1 wild-type background. All truncations were detected in these extracts; but the protein levels varied (Fig. 2B) . yth1DN2 was expressed at higher levels than wildtype. The level of yth1DZ2 was reduced compared to wildtype and degraded product was also detected (Fig. 2B, lane 2) , but the level of full-length protein was similar to that seen for the viable mutants yth1DC2 and yth1G130R. The protein levels of yth1DZ3/4 and yth1DZ4 were signi®cantly decreased when compared to the level of wild-type Yth1 (Fig. 2B, lanes  3 and 4) . These results suggest that poor expression may contribute to the lethality of these two deletions. We do not know whether these particular mutations are inherently unstable in vivo, or if poor incorporation into CPF, especially in competition with the endogenous wild-type Yth1, results in free mutant yth1 that is recognized as abnormal and targeted for degradation. As shown below, the fact that recombinant yth1DZ4 could rescue the critical function of cleavage in a yth1-defective extract is strong support that the protein is folding properly.
We next examined whether the various Yth1 mutations could function in cleavage and polyadenylation in vitro and if they exhibited wild-type interactions with Fip1, Brr5 and RNA, as described in the following sections.
Effects of mutations on processing in vitro
To further de®ne the role of Yth1 in processing, we ®rst prepared extracts from the viable mutant strains grown at permissive temperature and tested them for cleavage in vitro using the radioactive substrate GAL7-1 that contains the GAL7 poly(A) site and¯anking sequences. Poly(A) addition was assayed using the radioactive substrate GAL7-9 that ended at the GAL7 poly(A) site. Reactions were performed for 30 min; we have found that very little additional processing occurs after this time period. When the full-length RNA was added to wild-type extract, 27% of the full-length RNA input was cleaved, and 97% of the cleaved RNA was polyadenylated (Fig. 3, lane 2) . When the pre-cleaved RNA was added to wild-type extract, 52% of the input RNA was polyadenylated (Fig. 3, lane 7) . In extract from the strain carrying yth1DN1, cleavage activity was not detectable (Fig. 3, lane 3) and polyadenylation activity was greatly reduced (Fig. 3, lane 8) . This result con®rms that Yth1 is required in both processing steps, as shown by Barabino et al. (41) . Extract prepared from the strain carrying yth1DC2 was somewhat reduced for cleavage activity (Fig. 3, lane 4) but much more severely affected for polyadenylation in comparison to YTH1 extract (Fig. 3, lane 9) . Extract from the strain carrying yth1G130R showed a similar level of activity as wild-type in cleavage (33%) (Fig. 3, lane 5) , but a weakened polyadenylation activity of 62% (compared to 97% for wild-type). The defect in polyadenylation is also evident from the accumulation of cleavage product compared to wild-type extract (Fig. 3, lanes  3 and 5) .
To determine whether in vitro processing can be rescued by exogenous Yth1, we carried out complementation assays. We used extract from the yth1-4 strain, which carries a point mutation in ZF2 (41) , and recombinant Yth1 and mutated proteins expressed in E.coli as GST fusions. Reactions were performed in the presence of dATP to block poly(A) addition. None of the recombinant proteins showed any cleavage activity on their own (Fig. 4, lanes 11±16 ). As reported previously (41), the yth1-4 extract showed very weak processing activity in both steps, but could be rescued for cleavage with wild-type protein. Addition of recombinant GST-Yth1 stimulated cleavage activity, with 27% of the input RNA being processed, compared to 42% for wild-type extract (Fig. 4, lanes 3 and 6) . Recombinant GST-yth1DZ4 and GSTyth1DC2 proteins could also stimulate cleavage, but less ef®ciently than that of wild-type GST-Yth1 (Fig. 4, lanes 9  and 10) . Recombinant GST-yth1DN2 and GST-yth1DZ2 proteins could not rescue cleavage (Fig. 4, lanes 7 and 8) . These results indicate that ZF4 and ZF5 are not required for the cleavage function of Yth1.
Barabino et al. (41) found that GST-Yth1 could not rescue the poly(A) addition defect of yth1-4 extract. We obtained a similar result, with no reconstitution of polyadenylation with GST-Yth1 in extracts from the strains yth1-4, yth1DN1 and yth1DC2, even if the extract was supplemented with Fip1 and Pap1, or pre-treated at 37°C to try to destabilize the heat-labile mutants (data not shown). Moreover, the GST-YTH1 fusion was able to cover a disruption of the wild-type YTH1 gene in vivo, and removal of the N-terminal tag on recombinant Yth1 did not activate polyadenylation activity in vitro. This data supports the previously proposed hypothesis (41) that recombinant Yth1 is unable to displace the endogenous mutant yth1 from interactions with CPF subunits critical for polyadenylation. 
Domains of Yth1 involved in protein±protein and protein±RNA interactions
By co-immunoprecipitation assays, Yth1 was shown to interact directly with Fip1 (41, 51) . We carried out similar assays with the recombinant Yth1 deletion series and His 6 -tagged Fip1, in order to determine the Fip1 interaction domain of Yth1 (Fig. 5) . Two mutants, yth1DZ3/4 and yth1DZ4, did not co-immunoprecipitate with His 6 -Fip1 (Fig. 5A, lanes 6  and 7) , but all other Yth1 derivatives, including yth1DZ3, were immunoprecipitated. Barabino et al. (41) reported that the yth1-1 protein with a deletion of the C-terminal 50 amino acids is impaired in the interaction with Fip1. Similarly, we found that the pull-down of yth1DC2 by His 6 -Fip1 was somewhat less ef®cient than that of wild-type, but reproducibly detectable, and in striking contrast to the lack of binding of yth1DZ4 (Fig. 5A, lane 8) . These results indicate that ZF4 is necessary for Fip1 interaction, and that ZF5 probably stabilizes this interaction but is not required. Furthermore, when in vitro translated yth1G130R was used for coimmunoprecipitation instead of proteins expressed in E.coli, yth1G130R showed a weaker interaction with Fip1 compared to Yth1 (Fig. 5C) , consistent with the polyadenylation defect caused by this mutation. This result further supports the idea that ZF4 interacts with Fip1.
Yth1 also binds to the CPF subunit Brr5 (41), but the interaction domain has not been de®ned. We next performed a GST pull-down assay of GST-fused Yth1 truncations and recombinant His 6 -Brr5-HA 3 , to determine the Brr5 interaction domain of Yth1 (Fig. 6) . The wild-type and all of the truncations tested were able to pull down His 6 -Brr5-HA 3 , but GST-yth1DN2 and GST-yth1DZ4 exhibited a weaker interaction (Fig. 6, lanes 4 and 6) . Thus, ZF4 and the N-terminus including ZF1 both contribute to ef®cient binding of Brr5. It would not be surprising that Brr5, a relatively large protein (100 kDa) in comparison to Yth1 (24 kDa), contacted Yth1 in two places. The fact that Yth1 with the ZF4 deletion lost Fip1 binding and had a weakened Brr5 interaction raised the question of whether the Brr5±Yth1 interaction could compete with the Fip1±Yth1 interaction at ZF4. However, in a coimmunoprecipitation assay with all three proteins together, we found that His 6 -Fip1 and His 6 -Brr5-HA 3 can bind Yth1 at the same time without interference (data not shown).
By a primer extension assay, we found that Yth1 binds the U-rich stretches of GAL7 RNA (data not shown), similar to the previous study showing that Yth1 binds RNA with a preference for poly(U) (29) . The binding of Yth1 to poly(U) is very weak, and Barabino et al. (41) have used UV crosslinking, a more sensitive assay, to monitor the interaction of Yth1 and RNA. We have also found that this assay corresponds well with the ability of protein to bind RNA (40, 54) . Thus, to determine the RNA interaction domains of Yth1, we performed UV cross-linking with GST-fused Yth1 derivatives and radiolabeled GAL7-1 RNA. As shown in Figure 7 , GSTYth1 and two truncations, GST-yth1DN2 and GST-yth1DC2, cross-linked to RNA with comparable ef®ciencies (Fig. 7A,  lanes 1, 2 and 5 ). In contrast, the cross-linking of GSTyth1DZ2 and GST-yth1DZ4 to RNA was greatly reduced (Fig. 7A, lanes 3 and 4) . This ®nding suggests that ZF2 and ZF4 must both be present for normal interaction with RNA.
Fip1 blocks the interaction between Yth1 and RNA
Because ZF4 is needed for interaction with both Fip1 and RNA, we were curious as to whether the presence of Fip1 would interfere with the RNA interaction. To determine this, we performed a UV cross-linking assay using GST-Yth1 and radiolabeled GAL7-1 together with His 6 -Fip1 as a competitor. We ®rst incubated GST-Yth1 with various amounts of His 6 -Fip1 or His 6 -®p1-206, added RNA, and exposed the samples to UV light. The ®p1-206 derivative has a deletion of the Figure 8 , the cross-linking ef®ciency was greatly reduced as the amount of His 6 -Fip1 increased. When the GST-Yth1:His 6 -Fip1 molar ratio was 1:1, cross-linking ef®ciency dropped to 21% of that seen without Fip1 (Fig. 8B) . However, addition of His 6 -®p1-206 did not affect crosslinking ef®ciency. This result suggests that Fip1 occupancy of ZF4 inhibits the interaction of Yth1 with RNA.
DISCUSSION
While most of the components of the eukaryotic polyadenylation machinery have been identi®ed, little is known about the architecture of the complex or the function of many of the subunits. In this study, we have identi®ed domains in Yth1 important for the protein's activity and its interactions with RNA and the CPF subunits Fip1 and Brr5. The main conclusions from our study are: (i) ZF4 is important for all three interactions and for polyadenylation, but is dispensable for the function of Yth1 in cleavage; (ii) the unique N-terminus of Yth1 (before the ®ve zinc ®ngers) is essential for both cleavage and poly(A) addition; (iii) only four of the ®ve zinc ®ngers are necessary; (iv) Fip1 prevents the interaction of Yth1 and RNA. The results of this study are summarized in Figure 9 . This new data and the earlier studies with Yth1 (29, 41 ) support a functional organization of Yth1 in which the C-terminal part is dedicated to polyadenylation, while the N-terminal half is required for both processing steps.
Our deletion analysis indicates that the N-terminal half can be further subdivided into distinct functional domains. For example, removal of sequence before ZF1 causes a temperature-sensitive growth phenotype and gives extracts impaired for both cleavage and polyadenylation. Further truncation to eliminate ZF1 causes lethality and this mutant Yth1 cannot restore cleavage in vitro. However, there are no defects in the interaction with Fip1 or RNA, but there is reduced binding to Brr5. It is not clear at this time whether the functional de®cit due to loss of the N-terminus is related to the poor interaction with Brr5, or instead with another factor, which like Brr5, is essential for both steps of 3¢ end formation.
We have found that cells with a deletion of ZF2, also in the N-terminal half of Yth1, are not viable. An analysis by Barabino et al. (41) had demonstrated ZF2 to be critical for Yth1 function. In their temperature-sensitive yth1-4 allele, mutation of a conserved residue in this region (W70A) weakened interaction with the rest of CPF, but not with Fip1 or Brr5, and caused defects in both the cleavage and poly(A) addition steps. Recombinant yth1-4 protein also showed reduced cross-linking to RNA. Consistent with this study, we show that the yth1 protein completely lacking ZF2 could no longer interact well with RNA or rescue cleavage in vitro, but retained full interaction with Fip1 and Brr5. It is not known which CPF subunit contacts ZF2 of Yth1 and whether RNA binding and CPF interaction contribute equally to ZF2 function.
The central zinc ®nger, ZF3, can be eliminated without any consequences to cell survival. This result was surprising given that all of the Yth1 homologs from other species have ®ve zinc ®ngers (29) . In contrast, deletion of the next zinc ®nger, ZF4, located in the C-terminal half, was lethal. However, unlike yth1DZ2, yth1DZ4 can rescue cleavage in vitro. Interestingly, ZF4 is also important for the cross-linking of Yth1 to RNA. These two ®ndings suggest that contact with the RNA precursor through ZF4 must not be important for cleavage. In addition to the RNA binding defect, a ZF4 deletion results in complete loss of Fip1 binding and a weakened Brr5 interaction. Moreover, the fact that the G130R point mutation in ZF4 reduces the ef®ciency of Fip1 binding and impairs polyadenylation but not cleavage con®rms that Fip1 interaction is an important function of ZF4.
The ZF4 data is consistent with our previous work showing that extracts from cells with a disruption of the Yth1 binding domain on Fip1 (®p1-206) are inactive for polyadenylation (51) . This ®p1 mutant has completely lost Yth1 interaction, but is not affected in the ability to bind to Pap1 and to inhibit Pap1 activity. However, unlike the ZF4 deletion, a strain with this ®p1 mutation is viable unless grown at 37°C, suggesting that contacts made between the Fip1/Pap1 heterodimer and components of the polyadenylation complex other than Yth1 are suf®cient to incorporate these two proteins into the holoenzyme. This result, together with our new data, suggests that the essential nature of ZF4 in Yth1 is due to at least two functions: the interaction with Fip1 and the interaction with RNA.
The ®nal zinc ®nger, ZF5, is an important but non-essential domain of Yth1 that contributes to the ef®ciency of Fip1 binding. A deletion from the C-terminus which includes ZF5 (yth1DC2) causes slower growth at 37°C and extracts de®cient for poly(A) addition but not cleavage. Surprisingly, deletion of the C-terminus beyond the zinc ®ngers causes no effect on cell growth, even though the interaction with Fip1 may be somewhat diminished. Thus, interactions of Fip1 with ZF4 and ZF5 are suf®cient for normal polyadenylation.
By RNA cross-linking assays, we have found that Yth1 does not bind to RNA and Fip1 at the same time. One interpretation of this result is that ZF4 helps to mediate the switch from cleavage to polyadenylation. A model for this additional function of Yth1 is illustrated in Figure 9B . Fip1 binds Pap1 through a domain different from the one responsible for Yth1 interaction. At the cleavage step, Yth1, along with other CPF subunits, binds to RNA at the U-rich regions immediatelȳ anking the poly(A) site, but perhaps not tightly associated with Fip1. Following cleavage, Yth1 continues to bind RNA just upstream of the newly created 3¢ end. At this point, it may be important for Fip1 to displace Yth1 from RNA, so that Pap1 can access the 3¢ end and initiate poly(A) synthesis. Additional research is needed to understand what changes in the con®guration of the complex occur following cleavage and how these changes promote polyadenylation.
